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1. Introduction  
Sarcoidosis is a systemic disease that can involve almost any organ system. Infiltration with 
noncaseating granulomas is the hallmark of the disease, and it may result in various clinical 
manifestations 1. Cutaneous involvement occurs in 25% of patients with systemic sarcoidosis 
and may occur without systemic involvement. Because lesions assume a vast array of 
morphologies, cutaneous sarcoidosis is known as one of the “great imitators” in 
dermatology 2. The important specific lesions are lupus pernio, plaques and maculopapular 
eruptions. The most frequent nonspecific lesion is erythema nodosum. Other specific skin 
changes include subcutaneous nodules, erythema multiforme-like erythemas, alopecia, 
scars, verrucous outgrowths, psoriasiform lesions, ulcerative lesions, hypopigmentation, 
lichenoid lesions, ichthyosiform lesions and a sporadic type of erythroderma 1,2. 
Ichthyosiform and erythrodermic form of cutaneous sarcodosis are all rare presentation of 
cutaneous sarcodosis. The association of them in one case is extremely rare. To data, there 
are only three cases reported in English literature 3-5.  
2. Methods to use for diagnosis 
Correctly diagnosing sarcoidosis may be a challenge. Unfortunately, no single test can prove 
the diagnosis. Patients are diagnosed with sarcoidosis when a compatible clinical or 
radiologic picture is present, along with histologic evidence of noncaseating granulomas, 
and when other potential causes, such as infections, are excluded. The following tests are 
needed. 
Laboratory tests: Urine and blood routine examination; 24h amount of urine protein; Serum 
calcium and glucose, liver function and kidney function tests; Erythrocyte sedimentation 
rate; C-reaction protein, tuberculin test, antinuclear antibody. 
Cardiologic examination: Electrocardiography; 24h Holter monitoring electrocardiogram 
Ultrasonography: ultrasonography for liver, bladder, spleen, kidney, pancreas. 
X-ray: computer tomography scan of chest and abdomen 
Histopathologic examination: Biopsy for an eruption, a periodic acid-Schiff stain for fungi, a 
Ziehl-Nielsen stain for acid fast bacilli, and a Steiner stain are also needed to exclude 
infections. 
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Fig. 1. The flushing, swelling and dry scaling of skin were seen throughout the whole body 
in a 27-year-old Chinese female patient with ichthyosiform erythrodermia Sarcoidosis. The 
Ichthyosiform skin lesions especially seen in upper and lower extremities. 
3. Treatment protocol 
The treatment of cutaneous sarcoidosis is often frustrating, because lesions may be 
refractory to treatment or may recur following successful treatment. Systemic 
glucocorticoids are the most effective agents. They are commonly used at slow, tapering 
dosages, starting at 20 to 40 mg of oral prednisone daily for four to six weeks. Many other 
medications such as hydroxychloroquine (Plaquenil), methotrexate (Rheumatrex)and 
thalidomide (Thalomid) may be used in refractory cases 3,6,7 
4. Different diagnoses 
Acquired ichthyosis and erythrodermia in adult frequently signifies internal diseases, such 
as sarcoidosis, malignancy et al 8,9. The malignant condition included lymphomas, especially 
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Hodgkin's disease and mycosis fungoides, multiple myeloma; carcinomas of the lung, 
breast, and cervix; Kaposi's sarcoma; and leiomyosarcoma 2,8,9. Other systemic diseases that 
may be characterized by acquired ichthyosis include Hansen's disease, hypothyroidism, 
phrynoderma, and chronic malnutrition 1,10.  
5. Prognosis 
Sarcoidosis can affect any organ of the body but most commonly involves the lungs, lymph 
nodes, skin, and eyes. Less common but usually severe manifestations also occur in the 
central nervous system, heart, and skeletal system 2,4,8 Cutaneous manifestations are present 
in approximately 25 percent of patients and are classified as specific or nonspecific based 
upon the presence or absence of noncaseating granulomas on histopathologic examination 10. 
The relationship between cutaneous and systemic sarcoidosis is being studied. Cutaneous 
involvement in systemic sarcoidosis may occur at any stage of the disease. However, it is 
most often present at the onset and may even be the presenting complaint 11. Certain types 
of cutaneous lesions may have a bearing on prognosis of systemic sarcoidosis. Lesions of 
lupus pernio, erythrodermia, seem likely to associate with more severe systemic 
involvement, while erythema nodosum often indicates acute benign disease 3,4,8. Every 
patient with cutaneous sarcoidosis requires an initial work-up for systemic involvement, 
followed by periodic screening. 
6. Conclusion 
Sarcoidosis is a multisystem disease that may involve almost any organ system. 
Therefore, it results in various clinical manifestations. Cutaneous sarcoidosis is known as 
one of the “great imitators” in dermatology. Ichthyosiform and erythrodermic form of 
cutaneous sarcodosis is extremely rare. To data, there are only three cases reported in 
English literature. Sarcoidosis can affect any organ of the body but most commonly 
involves the lungs, lymph nodes, skin, and eyes. The Correctly diagnosing sarcoidosis 
may be a challenge. Unfortunately, no single test can prove the diagnosis. The treatment 
of cutaneous sarcoidosis is often frustrating. Systemic glucocorticoids are the most 
effective agents. 
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Sarcoidosis is a type of inflammation that occurs in various locations of the body for no known reason.
Normally, when foreign substances or organisms enter the body, the immune system will fight back by
activating an immune response. Inflammation is a normal part of this immune response, but it should subside
once the foreign antigen is gone. In sarcoidosis, the inflammation persists, and some of the immune cells form
abnormal clumps of tissue called granulomas. The disease can affect any organ in the body, but it is most
likely to occur in the lungs. It can also affect the skin, eyes, liver, or lymph nodes. Although the cause of
sarcoidosis is not known, research suggests that it may be due to an extreme immune response or extreme
sensitivity to certain substances. It also seems to have a genetic component as well, and tends to run in
families. Sarcoidosis most commonly develops in people between 20 and 50 years of age. African Americans
are somewhat more likely to develop sarcoidosis than Caucasians, and females are somewhat more likely to
develop sarcoidosis than males. The symptoms of sarcoidosis depend on the organ involved. This book deals
with the diagnosis and treatment of this mysterious disease of unknown etiology.
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